Skip to main content Accessibility help
×
Home
Hostname: page-component-568f69f84b-ftpnm Total loading time: 0.156 Render date: 2021-09-18T09:55:56.692Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Trends in Stenotrophomonas maltophilia Bloodstream Infection in Relation to Usage Density of Cephalosporins and Carbapenems During 7 Years

Published online by Cambridge University Press:  02 January 2015

Jorge G. Paez
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Anna S. Levin
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Mariusa Basso
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Laura B. Gomez
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Satiko Gobara
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Fernanda Spadão
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Isabel Oshiro
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Silvia Figueiredo Costa*
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
*Corresponding
Department of Infectious Diseases, Hospital das Clinicas of University of São Paulo, Av. Enéas de Carvalho Aguiar, n° 500-2°, Andar LIM54, CEP:05410-000, São Paulo, Brazil (costasilviaf@ig.com.br)
Rights & Permissions[Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

References

1.Sanyal, SC, Mokaddas, EM. The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen. J Chemother 1999;11:2833.CrossRefGoogle ScholarPubMed
2.Del Toro, MD, Rodriguez-Baño, J, Herrero, M, et al.Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection. Medicine 2002;81:228239.CrossRefGoogle ScholarPubMed
3.Carmeli, Y, Samore, H. Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study. Clin Infect Dis 1997;24:11311134.CrossRefGoogle ScholarPubMed
4.Meyer, E, Schwab, F, Gastmeier, P, Rüden, H, Daschner, FD. Is the prevalence of Stenotrophomonas maltophilia isolation and nosocomial infection increasing in intensive care units? Eur J Clin Microbiol Infect Dis 2006;25:711714CrossRefGoogle ScholarPubMed
5.Jones, RN, Sader, HS, Beach, ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18,569 strains of non-fermentative gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997–2001). Int J Antimicrob Agents 2003;22:551556.CrossRefGoogle Scholar
6.World Health Organization Collaborating Center For Drug Statistic Methodology. Anatomical Therapeutic Chemical (ATC) classification index with defined daily dose (DDD). 2008. Available at: http://www.whocc.no/atcddd/.Google Scholar
7.Krcmery, V Jr, Sykora, P, Trupl, J, et al.Antibiotic use and development of resistance in blood culture isolates: 8 years of experience from a cancer center. J Chemother 2001;13:133142.CrossRefGoogle Scholar
8.Metan, G, Hayran, M, Hascelik, G, Uzun, O. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis 2006;38:527531.CrossRefGoogle Scholar
You have Access
2
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Trends in Stenotrophomonas maltophilia Bloodstream Infection in Relation to Usage Density of Cephalosporins and Carbapenems During 7 Years
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Trends in Stenotrophomonas maltophilia Bloodstream Infection in Relation to Usage Density of Cephalosporins and Carbapenems During 7 Years
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Trends in Stenotrophomonas maltophilia Bloodstream Infection in Relation to Usage Density of Cephalosporins and Carbapenems During 7 Years
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *